FDA and CMS Launch RAPID Pathway for Faster Medicare Coverage of Breakthrough Devices
The FDA and CMS launched the RAPID pathway to speed Medicare coverage decisions for breakthrough medical devices through aligned reviews.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Health
Breast Cancer Cases Surge Among Women Under 50, Experts Warn
Breast cancer cases in U.S. women under 50 increased 1.4% annually from 2012-2022, driven by aggressive tumors and advanced-stage diagnoses.
Read More
CY 2027 Medicare Advantage Rule Delivers Wins but Weakens Plan Accountability
CMS finalized the 2027 Medicare Advantage rule, enhancing quality and access but reducing plan accountability by removing some performance metrics.
Read More
Healthy Sleep Patterns Linked to 26% Lower Pneumonia Risk in Major UK Cohort Study
A UK study of 360,000 adults found healthy sleep patterns linked to a 26% lower risk of pneumonia over 13 years.
Read More
HHS Secretary Kennedy Defends FY 2027 Budget Focus on Chronic Diseases and MFN Drug Pricing
HHS Secretary Kennedy defended the $111.1B FY 2027 budget prioritizing chronic disease prevention and Most Favored Nation drug pricing.
Read More
CMS Oversight Found Lacking on Compounded Drugs in Medicare Part D, OIG Audit Reveals
An OIG audit found CMS lacked sufficient oversight of compounded drugs in Medicare Part D from 2017-2019 due to incomplete data and reporting gaps.
Read More
Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies
Scientists discovered altered gene activity in excitatory neurons and microglia in depression patients, offering insights for targeted therapies.
Read More
Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers
Abbott survey finds 74% of Americans believe chronic diseases are preventable, citing confusion and costs as key barriers to effective health management.
Read More
White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses
The Justice Department reclassified cannabis as Schedule III, allowing FDA-approved medical marijuana research and expanded treatment options.
Read More
New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic
New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.
Read More